Financhill
Back

Fennec Pharmaceuticals, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
24

FRX.TO
Fennec Pharmaceuticals, Inc.

Last Price:
$10.39
Seasonality Move:
17.23%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
24
Fennec Pharmaceuticals, Inc. (FRX.TO) is a Sell

Is Fennec Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Fennec Pharmaceuticals, Inc. [FRX.TO] share price is $10.39. The Score for FRX.TO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • FRX.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FRX.TO Stock Price Chart

What is Fennec Pharmaceuticals, Inc.'s stock price today?

  • The Fennec Pharmaceuticals, Inc. share price today is $10.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

FRX.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.36 - 11.6) Sell
Bollinger Bands (100): (10.96 - 12.56) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

FRX.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.51 Sell
20-day SMA: 10.72 Sell
50-day SMA: 11.34 Sell
200-day SMA: 10.84 Sell
8-day EMA: 10.49 Sell
20-day EMA: 10.75 Sell
50-day EMA: 11.21 Sell
200-day EMA: 10.95 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Fennec Pharmaceuticals, Inc. Earnings Growth & FRX.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.25 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Fennec Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):